OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
59 hedge funds and large institutions have $113M invested in Oyster Point Pharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Holders
59
Holding in Top 10
2
Calls
$143K
Puts
$12K
Top Buyers
| 1 | +$1.77M | |
| 2 | +$565K | |
| 3 | +$408K | |
| 4 |
HF
HRT Financial
New York
|
+$235K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$214K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$1M | |
| 3 | -$470K | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
-$449K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$198K |